2-79651538-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001282597.3(CTNNA2):c.-5-14A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.196 in 1,600,996 control chromosomes in the GnomAD database, including 35,733 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.26 ( 6730 hom., cov: 32)
Exomes 𝑓: 0.19 ( 29003 hom. )
Consequence
CTNNA2
NM_001282597.3 intron
NM_001282597.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.47
Publications
6 publications found
Genes affected
CTNNA2 (HGNC:2510): (catenin alpha 2) Enables actin filament binding activity. Involved in negative regulation of Arp2/3 complex-mediated actin nucleation; regulation of neuron migration; and regulation of neuron projection development. Located in cytoplasm. Implicated in complex cortical dysplasia with other brain malformations. [provided by Alliance of Genome Resources, Apr 2022]
CTNNA2 Gene-Disease associations (from GenCC):
- cortical dysplasia, complex, with other brain malformations 9Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 2-79651538-A-G is Benign according to our data. Variant chr2-79651538-A-G is described in ClinVar as [Benign]. Clinvar id is 1255414.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.466 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.264 AC: 40080AN: 151930Hom.: 6696 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
40080
AN:
151930
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.219 AC: 54537AN: 248690 AF XY: 0.215 show subpopulations
GnomAD2 exomes
AF:
AC:
54537
AN:
248690
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.188 AC: 273051AN: 1448948Hom.: 29003 Cov.: 29 AF XY: 0.189 AC XY: 136591AN XY: 721668 show subpopulations
GnomAD4 exome
AF:
AC:
273051
AN:
1448948
Hom.:
Cov.:
29
AF XY:
AC XY:
136591
AN XY:
721668
show subpopulations
African (AFR)
AF:
AC:
16320
AN:
33164
American (AMR)
AF:
AC:
11047
AN:
44600
Ashkenazi Jewish (ASJ)
AF:
AC:
5378
AN:
26014
East Asian (EAS)
AF:
AC:
12652
AN:
39624
South Asian (SAS)
AF:
AC:
23135
AN:
85950
European-Finnish (FIN)
AF:
AC:
7024
AN:
53362
Middle Eastern (MID)
AF:
AC:
960
AN:
5738
European-Non Finnish (NFE)
AF:
AC:
184046
AN:
1100572
Other (OTH)
AF:
AC:
12489
AN:
59924
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
10949
21898
32846
43795
54744
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.264 AC: 40167AN: 152048Hom.: 6730 Cov.: 32 AF XY: 0.264 AC XY: 19622AN XY: 74326 show subpopulations
GnomAD4 genome
AF:
AC:
40167
AN:
152048
Hom.:
Cov.:
32
AF XY:
AC XY:
19622
AN XY:
74326
show subpopulations
African (AFR)
AF:
AC:
19537
AN:
41432
American (AMR)
AF:
AC:
3839
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
708
AN:
3470
East Asian (EAS)
AF:
AC:
1513
AN:
5152
South Asian (SAS)
AF:
AC:
1384
AN:
4820
European-Finnish (FIN)
AF:
AC:
1417
AN:
10604
Middle Eastern (MID)
AF:
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
AC:
11164
AN:
67982
Other (OTH)
AF:
AC:
483
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1404
2808
4211
5615
7019
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 11, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Cortical dysplasia, complex, with other brain malformations 9 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.